Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

NCT03840148 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

661

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infections
Acute Pyelonephritis

Interventions

DRUG: Cefepime/VNRX-5133 (taniborbactam)
DRUG: Meropenem

Sponsor

Venatorx Pharmaceuticals, Inc.